Efficacy of the XEN-Implant in Glaucoma and a Meta-Analysis of the Literature
Open Access
- 7 March 2021
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (5) , 1118
Abstract
Background: To assess the efficacy of XEN-implant surgery in patients with glaucoma, and to perform a meta-analysis of previously published results and compare these to our data. Methods: Prospective case-control study, in which all eyes that underwent XEN-implant surgery were included from 2015 onwards. Sub-analyses were performed for eyes that underwent XEN-implant as standalone procedure and as cataract-combined procedure. To compare our results, a systematic review was performed using the Embase, PubMed, Web of Science, and Cochrane database. Meta-analyses were performed by combining data (intraocular pressure (IOP), IOP-lowering medication, and complications) from the retrieved studies. Results: A total of 221 eyes underwent XEN-implant surgery (124 standalone and 97 cataract-combined). The mean ± standard deviation IOP declined from 18.8 ± 6.5 to 13.5 ± 4.3 mmHg at the last follow-up (p < 0.001; 28.9%). Postoperative, no significant differences in IOP or IOP-lowering medication were found between patients with and without combined procedure. Secondary surgeries were performed in 20.8% of eyes, most of them (63.0%) within six months. A meta-analysis of 19 studies retrieved from the systematic review showed a two-years postoperative pooled mean (weighted mean difference) of 14.5 (7.3) mmHg and 1.0 (1.6) for IOP and IOP-lowering medications, respectively (compared to 13.5 (5.3) mmHg and 3.2 (2.4) in the current study). Conclusion: XEN-implant surgery was effective and safe in lowering IOP and the number of IOP-lowering medications. There were no differences between standalone and combined procedures.Keywords
This publication has 33 references indexed in Scilit:
- One-year result of XEN45 implant for glaucoma: efficacy, safety, and postoperative managementEye, 2017
- Minimally invasive combined glaucoma and cataract surgery: clinical results of the smallest ab interno gel stentInternational Ophthalmology, 2017
- XEN Glaucoma Implant with Mitomycin C 1-Year Follow-Up: Result and ComplicationsJournal of Ophthalmology, 2017
- Ab interno approach to the subconjunctival space using a collagen glaucoma stentJournal of Cataract & Refractive Surgery, 2014
- The Ahmed Versus Baerveldt StudyOphthalmology, 2013
- The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and ElaborationPLOS Medicine, 2009
- Intraocular Pressure–Lowering Effects of All Commonly Used Glaucoma DrugsOphthalmology, 2005
- Measuring inconsistency in meta-analysesBMJ, 2003
- Meta-analysis of Observational Studies in EpidemiologyA Proposal for ReportingJAMA, 2000
- Glaucoma Care and Conformance with Preferred Practice PatternsOphthalmology, 1996